Answer
At recommended doses, the most common adverse reactions to alirocumab are local injection-site reactions (6.1%), upper respiratory tract signs and symptoms (2.0%), and pruritus (itching; 1.1%).
Sources for this answer
- Praluent 75 mg solution for injection in pre filled penSANOFI · emc · SmPC §4.8 Undesirable effects · Version 7Document updated
Sources checked